Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Clinical identification of malignant pleural effusions.

Journal article

Jia J. et al, (2023), Translational oncology, 39

Achieving Molecular Profiling in Pleural Biopsies

Journal article

Sundaralingam A. et al, (2023), Chest, 163, 1328 - 1339

Editorial: Reviews in thoracic oncology

Journal article

Kanellakis NI., (2023), Frontiers in Oncology, 13

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients

Journal article

Kanellakis NI. et al, (2019), BMJ Open Respiratory Research, 6, e000440 - e000440

Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification

Conference paper

Kanellakis NI. et al, (2019), EUROPEAN RESPIRATORY JOURNAL, 54

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study

Conference paper

Psallidas I. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197

BIOLOGICAL MARKERS OF FAVOURABLE PROGNOSIS AND SUCCESSFUL PLEURODESIS FOR MALIGNANT PLEURAL EFFUSION

Conference paper

Psallidas I. et al, (2016), THORAX, 71, A54 - A55

Biological markers of successful pleurodesis for malignant pleural effusion

Conference paper

Psallidas I. et al, (2016), 11.2 Pleural and Mediastinal Malignancies